Evidence map›Paper›PMID 30973827›Full record

ArticleJCI insight2019

Contractile and hemodynamic forces coordinate Notch1b-mediated outflow tract valve formation.

Jeffrey J Hsu, Vijay Vedula, Kyung In Baek, Cynthia Chen, Junjie Chen, Man In Chou, Jeffrey Lam, Shivani Subhedar, Jennifer Wang, Yichen Ding and 6 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Intercellular contractile force attenuates chemosensitivity through Notch-MVP-mediated nuclear drug export.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. The Interaction Between theInternational journal of molecular sciences · 2025
    Article
  10. Review
  11. Hemodynamics During Development and Postnatal Life.Advances in experimental medicine and biology · 2024
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Can't handle the stress? Mechanobiology and disease.Trends in molecular medicine · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Jeffrey J HsuDivision of Cardiology, Department of Medicine, UCLA, Los Angeles, California, USA.
Vijay VedulaDepartments of Pediatrics and Bioengineering, Stanford University, Stanford, California, USA.
Kyung In BaekDepartment of Bioengineering, UCLA, Los Angeles, California, USA.
Cynthia ChenDepartment of Bioengineering, UCLA, Los Angeles, California, USA.
Junjie ChenDepartment of Bioengineering, UCLA, Los Angeles, California, USA.
Man In ChouDepartment of Bioengineering, UCLA, Los Angeles, California, USA.
Jeffrey LamDepartment of Bioengineering, UCLA, Los Angeles, California, USA.
Shivani SubhedarDepartment of Bioengineering, UCLA, Los Angeles, California, USA.
Jennifer WangDepartment of Bioengineering, UCLA, Los Angeles, California, USA.
Yichen DingDepartment of Bioengineering, UCLA, Los Angeles, California, USA.
Chih-Chiang ChangDepartment of Bioengineering, UCLA, Los Angeles, California, USA.
Juhyun LeeDepartment of Bioengineering, University of Texas - Arlington, Arlington, Texas, USA.
Linda L DemerDivision of Cardiology, Department of Medicine, UCLA, Los Angeles, California, USA.
Yin TintutDivision of Cardiology, Department of Medicine, UCLA, Los Angeles, California, USA.
Alison L MarsdenDepartments of Pediatrics and Bioengineering, Stanford University, Stanford, California, USA.
Tzung K HsiaiDivision of Cardiology, Department of Medicine, UCLA, Los Angeles, California, USA.
La Jolla Bioengineering Institute · USStanford University · USUniversity of California, Los Angeles · USThe University of Texas at Arlington · US

Funding

CARDIOVASCULAR SCIENTIST TRAINING PROGRAMT32HL007895 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHIVKUMAR, KALYANAM, WATSON, KAROL E · 1998 to 2023
$9.2M
Genetic Studies of Sarcomere-based Cardiac Diseases (Diversity Supplement)R01HL081753 · NHLBI · MAYO CLINIC ROCHESTER · PI XU, XIAOLEI · 2005 to 2025
$7.8M
Shear Stress and Light-Sheets to Study Cardiac TrabeculationR01HL129727 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HSIAI, TZUNG K, MARSDEN, ALISON L · 2015 to 2024
$3.5M
Micro-Sensors to Study Electrical and Mechanical Coupling of Injured MyocardiumR01HL111437 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HSIAI, TZUNG K, XU, XIAOLEI · 2012 to 2020
$3.1M
NHLBI NIH HHS R01 HL081753NHLBI NIH HHS R01 HL111437NHLBI NIH HHS R01 HL129727NHLBI NIH HHS T32 HL007895
6 · The paper itself

Abstract

Biomechanical forces and endothelial-to-mesenchymal transition (EndoMT) are known to mediate valvulogenesis. However, the relative contributions of myocardial contractile and hemodynamic shear forces remain poorly understood. We integrated 4-D light-sheet imaging of transgenic zebrafish models with moving-domain computational fluid dynamics to determine effects of changes in contractile forces and fluid wall shear stress (WSS) on ventriculobulbar (VB) valve development. Augmentation of myocardial contractility with isoproterenol increased both WSS and Notch1b activity in the developing outflow tract (OFT) and resulted in VB valve hyperplasia. Increasing WSS in the OFT, achieved by increasing blood viscosity through EPO mRNA injection, also resulted in VB valve hyperplasia. Conversely, decreasing myocardial contractility by Tnnt2a morpholino oligonucleotide (MO) administration, 2,3-butanedione monoxime treatment, or Plcγ1 inhibition completely blocked VB valve formation, which could not be rescued by increasing WSS or activating Notch. Decreasing WSS in the OFT, achieved by slowing heart rate with metoprolol or reducing viscosity with Gata1a MO, did not affect VB valve formation. Immunofluorescent staining with the mesenchymal marker, DM-GRASP, revealed that biomechanical force-mediated Notch1b activity is implicated in EndoMT to modulate valve morphology. Altogether, increases in WSS result in Notch1b- EndoMT-mediated VB valve hyperplasia, whereas decreases in contractility result in reduced Notch1b activity, absence of EndoMT, and VB valve underdevelopment. Thus, we provide developmental mechanotransduction mechanisms underlying Notch1b-mediated EndoMT in the OFT.

Indexed as

Models, CardiovascularAnimalsAnimals, Genetically ModifiedBlood Flow VelocityBlood ViscosityComputer SimulationEndothelium, VascularEpithelial-Mesenchymal TransitionHeart ValvesMechanotransduction, CellularModels, AnimalMyocardial ContractionReceptor, Notch1Stress, MechanicalZebrafishZebrafish ProteinsNotch1b protein, zebrafishReceptor, Notch1Zebrafish ProteinsCardiologyCardiovascular diseaseDevelopmentEmbryonic development

Identifiers

PMID30973827
PMCPMC6542601
OpenAlexW2936934049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.